Congestive heart failure after anthracycline‐containing treatment for Hodgkin lymphoma: A Swedish matched cohort study

Congestive heart failure after anthracycline‐containing treatment for Hodgkin lymphoma: A Swedish matched cohort study

Abstract Introduction Congestive heart failure (CHF) is a known complication after anthracyclines and radiotherapy for classical Hodgkin lymphoma (cHL). Contemporary cHL treatment may be associated with less risk because radiotherapy use and techniques have changed substantially over time. Methods I...

Full description

Saved in:

Bibliographic Details
Main Authors:	Joachim Baech, Tarec Christoffer El‐Galaly, Joshua P. Entrop, Ingrid Glimelius, Daniel Molin, Sissel Johanne Godtfredsen, Michael J. Crowther, Karin E. Smedby, Sandra Eloranta, Caroline E. Dietrich
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.1048
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort studyResearch in context
by: Nanna Nørtoft Nielsen, et al.
Published: (2025-03-01)

Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer
by: Yuhan Wei, et al.
Published: (2025-01-01)

Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines
by: Vivian I. Franco, et al.
Published: (2011-01-01)

Clinical characteristics and outcomes of 476 mantle cell lymphoma patients aged 80 years and older
by: Simon Pahnke, et al.
Published: (2024-12-01)

Navigating Change: Experiences of Digitalisation Projects Within the Swedish Transport Administration
by: Fredrik Molin, et al.
Published: (2025-01-01)

CIRCULATION MICRORNA AS A POSSIBLE PREDICTOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: Maria Vladimirovna Khutornaya, et al.
Published: (2023-09-01)

Anthracyclines and Acquired Long QT Syndrome. A Case Report
by: Carlos Rodríguez Armada, et al.
Published: (2014-12-01)

DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA
by: Juan Eduardo Megias-Vericat, et al.
Published: (2019-02-01)

Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
by: Koichi Egashira, et al.
Published: (2022-06-01)

Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials
by: Zhao M, et al.
Published: (2025-01-01)

Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
by: Özlem Yersal, et al.
Published: (2018-01-01)

Prognosis Prediction of Cardiovascular Event With Glucose‐Albumin Ratio on Patients With Cancer and Prescribed With Anthracycline
by: Iokfai Cheang, et al.
Published: (2024-12-01)

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
by: Marijke Linschoten, et al.
Published: (2025-01-01)

Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
by: Sun Hee Chang, et al.
Published: (2015-01-01)

Previous treatment with anthracycline does not affect the course of sepsis in cancer patients: Retrospective cohort study
by: Camille Windsor, et al.
Published: (2025-01-01)

Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials.
by: Tao Ran, et al.
Published: (2024-01-01)

Concurrent Presentation of Hodgkin Lymphoma and Multiple Myeloma
by: Rekha Chandran, et al.
Published: (2013-01-01)

Swedish and foreign crimes in the Swedish criminal justice system
by: Alvar Nelson
Published: (1989-11-01)

EBV IN HODGKIN LYMPHOMA
by: Stefan Hohaus, et al.
Published: (2009-11-01)

Linfoma no Hodgkin mielorradicular
by: Jorge Nueva Matos, et al.
Published: (2020-04-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

EBV IN HODGKIN LYMPHOMA
by: Giuseppina Massini, et al.
Published: (2009-11-01)

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
by: John Lee, et al.
Published: (2024-12-01)

Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction
by: Tyler Shugg PharmD, PhD, et al.
Published: (2025-01-01)

Deciphering the cardioprotective effects of statins in anthracycline-related cardiac dysfunction: A systematic review and meta-analysis
by: Mubashar Karamat, et al.
Published: (2024-12-01)

A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
by: Bo Dai, et al.
Published: (2025-01-01)

Anthracyclines disaggregate and restore mutant p63 function: a potential therapeutic approach for AEC syndrome
by: Fabiana Boncimino, et al.
Published: (2025-01-01)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
by: S. E. Richardson, et al.
Published: (2011-01-01)

NonHodgkin's Lymphoma with Peritoneal Localization
by: E. Curakova, et al.
Published: (2014-01-01)

The Swedish Girl /
by: Gray, Alex
Published: (2013)

Primary T-Cell Non-Hodgkin Lymphoma of the Vagina
by: J. L. Herraiz, et al.
Published: (2015-01-01)

IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
by: Francesco Di Raimondo, et al.
Published: (2014-05-01)

PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
by: Annarosa Cuccaro, et al.
Published: (2014-07-01)

Early Continuity: The First Century of English-Swedish and Swedish-English Lexicography
by: Arne Olofsson
Published: (1991-05-01)

PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma
by: Genevieve Douglas, et al.
Published: (2025-02-01)

Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials
by: Armin Attar, et al.
Published: (2022-01-01)

Effect of supervised exercise training on objectively measured physical activity in patients during anthracycline therapyKey points
by: Caroline Schneider, et al.
Published: (2024-12-01)

The Digitalisation of Swedish Housing
by: Fredrik Torisson
Published: (2023-09-01)

Combined Utility of Speckle Tracking Echocardiography and Cardiac Biomarkers for Early Detection of Anthracycline-Induced Cardiotoxicity in Pediatric Oncology Patients
by: Cristiana Stolojanu, et al.
Published: (2024-12-01)

Linfoma no Hodgkin tipo MALT cerebral
by: Yaimara Zunen Hernández Puentes, et al.
Published: (2021-03-01)